Scopus BioPharma Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCPS research report →
Companyscopusbiopharma.com
Scopus BioPharma Inc. , a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers.
- CEO
- Alan D. Horsager
- IPO
- 2020
- Employees
- 13
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $16.83K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 911.69%
- ROIC
- 164.39%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-11,609,827 · 58.13%
- EPS
- $-0.55 · 65.84%
- Op Income
- $-11,714,877
- FCF YoY
- 28.87%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2.01
- Avg Volume
- 712
Get TickerSpark's AI analysis on SCPS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 23, 21 | Greenspan Ira Scott | other | 3,000,000 |
| Nov 23, 21 | Lamstein Joshua R | other | 3,000,000 |
| Jun 1, 21 | Hopper Paul | other | 6,333 |
| Dec 15, 20 | Hopper Paul | other | 0 |
| Oct 1, 21 | Hopper Paul | other | 0 |
| Oct 1, 21 | Hopper Paul | other | 0 |
| Dec 15, 20 | Hopper Paul | other | 0 |
| Aug 27, 21 | Greenspan Ira Scott | buy | 110 |
| Aug 27, 21 | Greenspan Ira Scott | buy | 790 |
| Aug 27, 21 | Lamstein Joshua R | buy | 200 |
Our SCPS Coverage
We haven't published any research on SCPS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SCPS Report →